• Je něco špatně v tomto záznamu ?

Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis

L. Murgasova, M. Jurovcik, P. Jesina, V. Malinova, M. Bloomfield, J. Zeman, M. Magner,

. 2020 ; 135 (-) : 110137. [pub] 20200527

Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20027970

OBJECTIVES: The mucopolysaccharidoses (MPS) are inherited lysosomal storage disorders with multisystemic and highly variable clinical manifestation. ENT symptoms are common and early signs of MPS. The most common ENT diagnoses are chronic/recurrent rhinosinusitis, acute otitis media, otitis media with effusion, hearing loss and airway obstruction. METHODS: A single-centre retrospective chart review of 61 patients (36 M/25F) with different MPS subtypes (MPS I (n = 15), MPS II (n = 10), MPS III (n = 17), MPS IV (n = 15) and MPS VI (n = 4)) was conducted. The age of ENT presentation and frequency of ENT symptoms, surgeries and their distribution among MPS subtypes was studied. The relationship between ENT presentation, first ENT surgery and the age of diagnosis was also evaluated. RESULTS: Median age at the first ENT manifestation was 2.8 years, median age at MPS diagnosis 4.1 years. The great majority of patients (90%) manifested at least one ENT diagnosis; often before the diagnosis of MPS (75%). Chronic/recurrent rhinosinusitis was the most prevalent ENT diagnosis (77%), followed by upper airway obstruction (65%) and hearing loss (53%). Chronic/recurrent rhinosinusitis was the first ENT symptom to appear (median age 2.2 years), followed by otitis media with effusion (3.7 years) and hearing loss (4.5 years). At least one ENT surgery was performed in 57% of patients; in 69% before MPS diagnosis was established. Median age of the first ENT surgery was 4.1 years. ENT symptoms and surgical procedures were earliest present in MPS II. CONCLUSIONS: Our study documents high and early occurrence of various otolaryngologic symptoms in MPS and thus highlights the role of ENT specialist in prompt diagnosis of these rare diseases and their long-term management.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027970
003      
CZ-PrNML
005      
20210114152719.0
007      
ta
008      
210105s2020 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijporl.2020.110137 $2 doi
035    __
$a (PubMed)32502916
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Murgasova, Lenka $u Department of Pediatrics and Adolescent Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic; Department of ENT, Motol University Hospital and Second Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis / $c L. Murgasova, M. Jurovcik, P. Jesina, V. Malinova, M. Bloomfield, J. Zeman, M. Magner,
520    9_
$a OBJECTIVES: The mucopolysaccharidoses (MPS) are inherited lysosomal storage disorders with multisystemic and highly variable clinical manifestation. ENT symptoms are common and early signs of MPS. The most common ENT diagnoses are chronic/recurrent rhinosinusitis, acute otitis media, otitis media with effusion, hearing loss and airway obstruction. METHODS: A single-centre retrospective chart review of 61 patients (36 M/25F) with different MPS subtypes (MPS I (n = 15), MPS II (n = 10), MPS III (n = 17), MPS IV (n = 15) and MPS VI (n = 4)) was conducted. The age of ENT presentation and frequency of ENT symptoms, surgeries and their distribution among MPS subtypes was studied. The relationship between ENT presentation, first ENT surgery and the age of diagnosis was also evaluated. RESULTS: Median age at the first ENT manifestation was 2.8 years, median age at MPS diagnosis 4.1 years. The great majority of patients (90%) manifested at least one ENT diagnosis; often before the diagnosis of MPS (75%). Chronic/recurrent rhinosinusitis was the most prevalent ENT diagnosis (77%), followed by upper airway obstruction (65%) and hearing loss (53%). Chronic/recurrent rhinosinusitis was the first ENT symptom to appear (median age 2.2 years), followed by otitis media with effusion (3.7 years) and hearing loss (4.5 years). At least one ENT surgery was performed in 57% of patients; in 69% before MPS diagnosis was established. Median age of the first ENT surgery was 4.1 years. ENT symptoms and surgical procedures were earliest present in MPS II. CONCLUSIONS: Our study documents high and early occurrence of various otolaryngologic symptoms in MPS and thus highlights the role of ENT specialist in prompt diagnosis of these rare diseases and their long-term management.
650    _2
$a mladiství $7 D000293
650    _2
$a věkové faktory $7 D000367
650    _2
$a obstrukce dýchacích cest $x etiologie $7 D000402
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a chronická nemoc $7 D002908
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nedoslýchavost $x etiologie $7 D034381
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mukopolysacharidózy $x komplikace $x diagnóza $7 D009083
650    _2
$a mukopolysacharidóza I $x komplikace $x diagnóza $7 D008059
650    _2
$a mukopolysacharidóza II $x komplikace $x diagnóza $7 D016532
650    _2
$a mukopolysacharidóza III $x komplikace $x diagnóza $7 D009084
650    _2
$a mukopolysacharidóza IV $x komplikace $x diagnóza $7 D009085
650    _2
$a mukopolysacharidóza VI $x komplikace $x diagnóza $7 D009087
650    _2
$a otitis media s výpotkem $x etiologie $7 D010034
650    _2
$a otorinolaryngologické chirurgické výkony $7 D013517
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rýma $x etiologie $7 D012220
650    _2
$a sinusitida $x etiologie $7 D012852
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jurovcik, Michal $u Department of ENT, Motol University Hospital and Second Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Jesina, Pavle $u Department of Pediatrics and Adolescent Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Malinova, Vera $u Department of Pediatrics and Adolescent Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Bloomfield, Marketa $u Department of Immunology, Motol University Hospital and Second Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Pediatrics, Thomayer's Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Zeman, Jiri $u Department of Pediatrics and Adolescent Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Magner, Martin $u Department of Pediatrics and Adolescent Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Pediatrics, Thomayer's Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: martin.magner@vfn.cz.
773    0_
$w MED00002355 $t International journal of pediatric otorhinolaryngology $x 1872-8464 $g Roč. 135, č. - (2020), s. 110137
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32502916 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152717 $b ABA008
999    __
$a ok $b bmc $g 1608305 $s 1119150
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 135 $c - $d 110137 $e 20200527 $i 1872-8464 $m International journal of pediatric otorhinolaryngology $n Int J Pediatr Otorhinolaryngol $x MED00002355
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace